1.0598
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.04
Aprire:
$1.05
Volume 24 ore:
4,810
Relative Volume:
0.04
Capitalizzazione di mercato:
$66.35M
Reddito:
$33.79M
Utile/perdita netta:
$-18.67M
Rapporto P/E:
-2.9587
EPS:
-0.3582
Flusso di cassa netto:
$-19.17M
1 W Prestazione:
+2.89%
1M Prestazione:
-10.19%
6M Prestazione:
+3.90%
1 anno Prestazione:
+0.93%
Cytosorbents Corp Stock (CTSO) Company Profile
Nome
Cytosorbents Corp
Settore
Industria
Telefono
973-329-8885
Indirizzo
305 COLLEGE ROAD EAST, PRINCETON, NJ
Confronta CTSO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CTSO
Cytosorbents Corp
|
1.0598 | 65.74M | 33.79M | -18.67M | -19.17M | -0.3582 |
![]()
ABT
Abbott Laboratories
|
124.73 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.66 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
392.12 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
90.79 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.73 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-09-07 | Iniziato | B. Riley Securities | Buy |
2021-10-14 | Ripresa | B. Riley Securities | Buy |
2020-09-17 | Iniziato | Jefferies | Buy |
2020-09-01 | Iniziato | SVB Leerink | Outperform |
2017-08-08 | Reiterato | Maxim Group | Buy |
2016-10-26 | Iniziato | Aegis Capital | Buy |
2016-05-24 | Iniziato | Maxim Group | Buy |
2015-10-29 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
2015-05-12 | Reiterato | MLV & Co | Buy |
2015-04-01 | Reiterato | MLV & Co | Buy |
2015-03-05 | Iniziato | MLV & Co | Buy |
2015-02-25 | Iniziato | WBB Securities | Speculative Buy |
2015-01-27 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Cytosorbents Corp Borsa (CTSO) Ultime notizie
Why Cytosorbents Corporation stock attracts strong analyst attentionVerified Return Tips - Newser
Cytosorbents (NASDAQ:CTSO) Given “Buy” Rating at D. Boral Capital - Defense World
What analysts say about Cytosorbents Corporation stockExceptional risk-adjusted gains - jammulinksnews.com
Is Cytosorbents Corporation a good long term investmentExtraordinary profit generation - jammulinksnews.com
What drives Cytosorbents Corporation stock priceMassive wealth growth - jammulinksnews.com
What institutions are buying Cytosorbents Corporation stock nowLong Term Low Risk Growth - Newser
What makes Cytosorbents Corporation stock price move sharplyRisk Controlled Trading Ideas - Newser
Cytosorbents stock plunges after regulatory setbacks for key device - Investing.com
CytoSorbents provides FDA, Health Canada regulatory update for DrugSorb-ATR - TipRanks
Cytosorbents Provides U.S. FDA And Health Canada Regulatory Update For Drugsorb-Atr - TradingView
CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device - Investing.com
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR - PR Newswire
Cytosorbents Corporation(NasdaqCM: CTSO) added to Russell Microcap Index - MarketScreener
CytoSorbents files appeal with FDA over denied device application - Investing.com
CytoSorbents Q1 2025 slides: Revenue dips 3% as company targets breakeven by year-end - Investing.com
Millennium Management LLC Buys Shares of 33,280 Cytosorbents Co. (NASDAQ:CTSO) - Defense World
Cytosorbents announces voting results from annual meeting By Investing.com - Investing.com Canada
Cytosorbents announces voting results from annual meeting - Investing.com
CytoSorbents Warrants Expire Worthless as Stock Price Fails Threshold - Investing.com
Cytosorbents Co. (NASDAQ:CTSO) Shares Purchased by Northern Trust Corp - Defense World
Critical Care Leader CytoSorbents Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan
Cytosorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented At EuroPCR 2025 - marketscreener.com
CytoSorbents device cuts bleeding in CABG patients - Investing.com
New Clinical Data: How CytoSorbents' Breakthrough Device Slashes Severe Bleeding Risk in Urgent Heart Surgery - Stock Titan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Cytosorbents FY2025 EPS Forecast Lifted by HC Wainwright - Defense World
D. Boral Capital Reiterates “Buy” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World
Cytosorbents (NASDAQ:CTSO) Earns Neutral Rating from HC Wainwright - Defense World
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript - Insider Monkey
Cytosorbents Corp’s Earnings Call: A Balanced Outlook - TipRanks
CytoSorbents (CTSO) Receives Neutral Rating from HC Wainwright & Co. | CTSO Stock News - GuruFocus
CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | - GuruFocus
CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | CTSO Stock News - GuruFocus
CytoSorbents: Q1 Earnings Snapshot - CT Insider
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and Strengthening Financials - GuruFocus
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents (CTSO) Targets Growth Amid Regulatory Challenges - GuruFocus
Earnings call transcript: CytoSorbents Q1 2025 misses earnings, stock dips - Investing.com
CytoSorbents Corp Q1 2025 Earnings: EPS of -$0.06 Beats Estimate, Revenue of $8.7M Misses Estimate - GuruFocus
CTSO Reports Q1 Revenue Below Expectations Amid Strategic Changes in Germany | CTSO Stock News - GuruFocus
Cytosorbents Corp Azioni (CTSO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):